Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.

Grade Last Price % Change Price Change
F 16.57 2.28% 0.37
CRBP closed up 2.28 percent on Wednesday, October 30, 2024, on 34 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 5
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 2.28%
Doji - Bullish? Reversal 2.28%
Oversold Stochastic Weakness 2.28%
NR7 Range Contraction 1.41%
Narrow Range Bar Range Contraction 1.41%
Lower Bollinger Band Walk Weakness 1.41%
Inside Day Range Contraction 1.41%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 16 hours ago
Up 5% about 16 hours ago
Up 3% about 17 hours ago
Rose Above Previous Day's High about 17 hours ago
Outside Day about 17 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Hearing Cystic Fibrosis Hearing Aid Fibrotic Disease Treatment Of Cystic Fibrosis Ajulemic Acid Channelopathies Scleroderma

Is CRBP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 61.9
52 Week Low 3.0334
Average Volume 737,591
200-Day Moving Average 38.84
50-Day Moving Average 34.05
20-Day Moving Average 18.04
10-Day Moving Average 17.08
Average True Range 1.74
RSI (14) 27.01
ADX 49.5
+DI 11.78
-DI 36.82
Chandelier Exit (Long, 3 ATRs) 15.66
Chandelier Exit (Short, 3 ATRs) 21.15
Upper Bollinger Bands 20.40
Lower Bollinger Band 15.68
Percent B (%b) 0.19
BandWidth 26.16
MACD Line -4.29
MACD Signal Line -5.25
MACD Histogram 0.9561
Fundamentals Value
Market Cap 171.28 Million
Num Shares 10.3 Million
EPS -11.12
Price-to-Earnings (P/E) Ratio -1.49
Price-to-Sales 163.32
Price-to-Book 744.81
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.36
Resistance 3 (R3) 18.35 17.74 18.07
Resistance 2 (R2) 17.74 17.28 17.75 17.97
Resistance 1 (R1) 17.15 17.00 17.45 17.17 17.87
Pivot Point 16.54 16.54 16.69 16.55 16.54
Support 1 (S1) 15.96 16.09 16.25 15.97 15.27
Support 2 (S2) 15.35 15.80 15.35 15.17
Support 3 (S3) 14.76 15.35 15.07
Support 4 (S4) 14.78